In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 22929-52-8, name is Dihydrofuran-3(2H)-one, introducing its new discovery. Quality Control of Dihydrofuran-3(2H)-one
Substituted pyrazolo-piperazines as casein kinase 1 delta/epsilon inhibitors
The invention provides compounds of Formula (I): and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 22929-52-8, and how the biochemistry of the body works.Quality Control of Dihydrofuran-3(2H)-one
Reference:
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem